Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2006 1
2007 1
2010 1
2015 2
2016 3
2018 1
2020 2
2021 1
2022 1
2023 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.
Bergeron A, Chevret S, Chagnon K, Godet C, Bergot E, Peffault de Latour R, Dominique S, de Revel T, Juvin K, Maillard N, Reman O, Contentin N, Robin M, Buzyn A, Socié G, Tazi A. Bergeron A, et al. Am J Respir Crit Care Med. 2015 Jun 1;191(11):1242-9. doi: 10.1164/rccm.201410-1818OC. Am J Respir Crit Care Med. 2015. PMID: 25835160 Clinical Trial.
RATIONALE: Systemic steroids are the standard treatment for bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic stem cell transplantation (HSCT) despite their poor efficacy and disabling side effects. ...The effect of budesonide/formoterol …
RATIONALE: Systemic steroids are the standard treatment for bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoi …
Efficacy of inhaled tiotropium add-on to budesonide/formoterol in patients with bronchiolitis obliterans developing after hematopoietic stem cell transplantation.
Lim JU, Park S, Yoon JH, Lee SE, Cho BS, Kim YJ, Lee S, Kim HJ, Rhee CK. Lim JU, et al. Respir Med. 2023 Nov;218:107410. doi: 10.1016/j.rmed.2023.107410. Epub 2023 Sep 9. Respir Med. 2023. PMID: 37696312 Free article.
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is the lung manifestation of chronic graft-versus-host disease after hematopoietic stem cell transplantation (HSCT). ...Patients defined as BOS and treated with budesonide/formoterol/tiotropium combination t …
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is the lung manifestation of chronic graft-versus-host disease after hemat …
Therapeutic effect of budesonide, montelukast and azithromycin on post-infectious bronchiolitis obliterans in children.
Chen X, Shu JH, Huang Y, Long Z, Zhou XQ. Chen X, et al. Exp Ther Med. 2020 Sep;20(3):2649-2656. doi: 10.3892/etm.2020.8983. Epub 2020 Jul 9. Exp Ther Med. 2020. PMID: 32765758 Free PMC article.
Optimal treatment options for post-infectious bronchiolitis obliterans (PIBO) have not yet been established. The present study retrospectively analyzed the effect of budesonide, montelukast and azithromycin on treating PIBO in children <5 years old.. Based …
Optimal treatment options for post-infectious bronchiolitis obliterans (PIBO) have not yet been established. The present study …
Efficacy and safety of high-dose budesonide/formoterol in patients with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplant.
Kim KH, Lee J, Kim HJ, Lee S, Kim YJ, Lee JH, Rhee CK. Kim KH, et al. J Thorac Dis. 2020 Aug;12(8):4183-4195. doi: 10.21037/jtd-19-3475. J Thorac Dis. 2020. PMID: 32944330 Free PMC article.
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is a rare, progressive and irreversible airway disease associated with significant mortality after allogeneic hematopoietic stem-cell transplantation (HSCT). In this study, we investigated the therapeutic effect of …
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is a rare, progressive and irreversible airway disease associated with sig …
Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Kim SW, Rhee CK, Kim YJ, Lee S, Kim HJ, Lee JW. Kim SW, et al. Respir Res. 2016 May 26;17(1):63. doi: 10.1186/s12931-016-0380-1. Respir Res. 2016. PMID: 27229850 Free PMC article.
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic stem cell transplantation (HSCT) is currently treated with systemic corticosteroids despite poor efficacy and side effects. This study investigated the therapeutic effect of budeso …
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic stem cell transplantation (HSCT) is current …
Follow-up on the therapeutic effects of a budesonide, azithromycin, montelukast, and acetylcysteine (BAMA) regimen in children with post-infectious bronchiolitis obliterans.
Weng T, Lin X, Wang L, Lv J, Dong L. Weng T, et al. J Thorac Dis. 2021 Aug;13(8):4775-4784. doi: 10.21037/jtd-20-3195. J Thorac Dis. 2021. PMID: 34527318 Free PMC article.
BACKGROUND: Post-infectious bronchiolitis obliterans (PIBO) is a rare, severe chronic lung disease without optimal treatment. ...This study aimed to evaluate the short-term efficacy of the budesonide, azithromycin, montelukast, and acetylcysteine (BAMA) regim …
BACKGROUND: Post-infectious bronchiolitis obliterans (PIBO) is a rare, severe chronic lung disease without optimal treatment. …
Clinical features of postinfectious bronchiolitis obliterans in children undergoing long-term nebulization treatment.
Zhang XM, Lu AZ, Yang HW, Qian LL, Wang LB, Zhang XB. Zhang XM, et al. World J Pediatr. 2018 Oct;14(5):498-503. doi: 10.1007/s12519-018-0193-z. Epub 2018 Sep 29. World J Pediatr. 2018. PMID: 30269305
BACKGROUND: Limited data are available in relation to the clinical features of PIBO undergoing prolonged nebulization treatment with budesonide, terbutaline and ipratropium bromide. This retrospective study aimed to outline the features of clinical, high-resolution compute …
BACKGROUND: Limited data are available in relation to the clinical features of PIBO undergoing prolonged nebulization treatment with bude …
[Mesenchymal Stem Cells Combined with Budesonide, Almeterol and Azithromycin for the Treatment of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation].
Cao XP, Han DM, Wang ZD, Zheng XL, Ding L, Yan HM, Xue M, Zhu L, Liu J, Guo ZK, Wang HX. Cao XP, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):173-7. doi: 10.7534/j.issn.1009-2137.2016.01.033. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 26913416 Chinese.
OBJECTIVE: To evaluate the safety and effectiveness of a novel therapeutic regimen for bronchiolitis obliterans sydrome (BOS) affter hematopoietic stem cell transplantation (HSCT). ...They received weekly intravenous injection of umbilical cord-derived mesenchymal s …
OBJECTIVE: To evaluate the safety and effectiveness of a novel therapeutic regimen for bronchiolitis obliterans sydrome (BOS) …
Effects of Inhaled Corticosteroids on Lung Function in Children With Post-infectious Bronchiolitis Obliterans in Remission.
Zheng H, Yu X, Chen Y, Lin W, Liu L. Zheng H, et al. Front Pediatr. 2022 May 10;10:827508. doi: 10.3389/fped.2022.827508. eCollection 2022. Front Pediatr. 2022. PMID: 35620151 Free PMC article.
BACKGROUND: Post-infectious bronchiolitis obliterans (PIBO) is a rare and irreversible chronic obstructive pulmonary disease with no specific treatment, especially for patients with PIBO in remission. ...
BACKGROUND: Post-infectious bronchiolitis obliterans (PIBO) is a rare and irreversible chronic obstructive pulmonary disease w …
17 results